Prenatal Plasma Fibrinogen Level Predicts Postpartum Hemorrhage of Patients With HELLP Syndrome

Overview

Journal Clin Appl Thromb Hemost

Publisher Sage Publications

Specialty Cardiology & Vascular Diseases

Date 2020 Feb 5

PMID 32013532

Citations 2

Authors

Chanjuan Cui

Sisi Ma

Rui Qiao

Affiliations

Soon will be listed here.

Abstract

emolysis, levated iver enzymes, and ow latelets (HELLP) syndrome is a serious complication of pregnancy. Postpartum hemorrhage indicates poor prognosis of pregnant women with HELLP syndrome. The aim of our study is to investigate the predictive value of coagulation markers for postpartum hemorrhage of pregnant women with HELLP syndrome. In a retrospective cohort study, 106 patients who were diagnosed as pregnant women with HELLP syndrome in Peking University Third Hospital from August 2010 to January 2017 were analyzed. The demographic characters of maternal and fetus, days of hospital stay, postpartum complications, and the laboratory tests of coagulation markers within 3 days before delivery were collected. In addition, 100 healthy pregnant women were collected as a control group. The result showed that the incidence of preeclampsia in pregnant women with postpartum hemorrhage was higher than that in pregnant women without hemorrhage ( = .011). The level of fibrinogen (FIB) in postpartum hemorrhage pregnant women with HELLP syndrome was lower than that in nonpostpartum hemorrhage pregnant women with HELLP syndrome and healthy pregnant women (2.3 [1.68-2.81] vs 3.64 ± 0.95, = .000; 2.3 [1.68-2.81] vs 4.48 ± 0.62, = .000). Multivariate analysis showed that decreased FIB levels independently predicted the postpartum hemorrhage of pregnant women with HELLP syndrome (odds ratio = 7.374, 95% confidence interval [CI], 1.551-35.05, = .012). The receiver operating characteristic curve showed that the area under the curve of FIB level when predicting postpartum hemorrhage is 0.841 (95% CI, 0.708-0.976). When the cutoff value of FIB was 3.04 g/L, the sensitivity was 90.90% and the specificity was75.80%. Therefore, the low level of prenatal FIB is a reliable biomarker to predict postpartum hemorrhage of pregnant women with HELLP syndrome, which make it useful for pregnant women with HELLP syndrome in guiding surveillance therapy and prognosis assessment.

Citing Articles

Accuracy of machine learning and traditional statistical models in the prediction of postpartum haemorrhage: a systematic review.

Baeta T, Rocha A, Oliveira J, Couto da Silva A, Reis Z BMJ Open. 2025; 15(3):e094455.

PMID: 40032385 PMC: 11877273. DOI: 10.1136/bmjopen-2024-094455.

Association Between Laboratory Coagulation Parameters and Postpartum Hemorrhage in Preterm and Term Caesarean Section: A Retrospective Analysis.

Dibiasi C, Jecel E, Falcone V, Schaden E, Gratz J J Clin Med. 2024; 13(21).

PMID: 39518742 PMC: 11545883. DOI: 10.3390/jcm13216604.

Clinical Classification, Pregnancy Outcomes and Risk Factors Analysis of Severe Preeclampsia Complicated With HELLP Syndrome.

Huang H, Liu B, Gao X, Wang Y Front Surg. 2022; 9:859180.

PMID: 35360419 PMC: 8963866. DOI: 10.3389/fsurg.2022.859180.

References

Barton J, Sibai B . Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome. Clin Perinatol. 2004; 31(4):807-33, vii. DOI: 10.1016/j.clp.2004.06.008. View

Newsome J, Martin J, Bercu Z, Shah J, Shekhani H, Peters G . Postpartum Hemorrhage. Tech Vasc Interv Radiol. 2017; 20(4):266-273. DOI: 10.1053/j.tvir.2017.10.007. View

Martin Jr J, Brewer J, Wallace K, Sunesara I, Canizaro A, Blake P . Hellp syndrome and composite major maternal morbidity: importance of Mississippi classification system. J Matern Fetal Neonatal Med. 2013; 26(12):1201-6. DOI: 10.3109/14767058.2013.773308. View

Rimaitis K, Grauslyte L, Zavackiene A, Baliuliene V, Nadisauskiene R, Macas A . Diagnosis of HELLP Syndrome: A 10-Year Survey in a Perinatology Centre. Int J Environ Res Public Health. 2019; 16(1). PMC: 6339138. DOI: 10.3390/ijerph16010109. View

Erez O, Novack L, Beer-Weisel R, Dukler D, Press F, Zlotnik A . DIC score in pregnant women--a population based modification of the International Society on Thrombosis and Hemostasis score. PLoS One. 2014; 9(4):e93240. PMC: 3984105. DOI: 10.1371/journal.pone.0093240. View

Sibai B . Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol. 2004; 103(5 Pt 1):981-91. DOI: 10.1097/01.AOG.0000126245.35811.2a. View

Westbrook R, Dusheiko G, Williamson C . Pregnancy and liver disease. J Hepatol. 2015; 64(4):933-45. DOI: 10.1016/j.jhep.2015.11.030. View

Chapin J, Hajjar K . Fibrinolysis and the control of blood coagulation. Blood Rev. 2014; 29(1):17-24. PMC: 4314363. DOI: 10.1016/j.blre.2014.09.003. View

Jebbink J, Wolters A, Fernando F, Afink G, van der Post J, Ris-Stalpers C . Molecular genetics of preeclampsia and HELLP syndrome - a review. Biochim Biophys Acta. 2012; 1822(12):1960-9. DOI: 10.1016/j.bbadis.2012.08.004. View

10.

Cui C, Yang S, Zhang J, Wang G, Huang S, Li A . Trimester-specific coagulation and anticoagulation reference intervals for healthy pregnancy. Thromb Res. 2017; 156:82-86. DOI: 10.1016/j.thromres.2017.05.021. View

11.

Haram K, Mortensen J, Mastrolia S, Erez O . Disseminated intravascular coagulation in the HELLP syndrome: how much do we really know?. J Matern Fetal Neonatal Med. 2016; 30(7):779-788. DOI: 10.1080/14767058.2016.1189897. View

12.

Oliveira N, Poon L, Nicolaides K, Baschat A . First trimester prediction of HELLP syndrome. Prenat Diagn. 2015; 36(1):29-33. DOI: 10.1002/pd.4694. View

13.

Benedetto C, Marozio L, Tancredi A, Picardo E, Nardolillo P, Tavella A . Biochemistry of HELLP syndrome. Adv Clin Chem. 2011; 53:85-104. DOI: 10.1016/b978-0-12-385855-9.00004-7. View

14.

Lockhart E . Postpartum hemorrhage: a continuing challenge. Hematology Am Soc Hematol Educ Program. 2015; 2015:132-7. DOI: 10.1182/asheducation-2015.1.132. View

15.

Ospina-Tascon G, Nieto Calvache A, Quinones E, Madrinan H, Valencia J, Bermudez W . Microcirculatory blood flow derangements during severe preeclampsia and HELLP syndrome. Pregnancy Hypertens. 2017; 10:124-130. DOI: 10.1016/j.preghy.2017.07.140. View

16.

Erez O, Mastrolia S, Thachil J . Disseminated intravascular coagulation in pregnancy: insights in pathophysiology, diagnosis and management. Am J Obstet Gynecol. 2015; 213(4):452-63. DOI: 10.1016/j.ajog.2015.03.054. View

17.

Martin Jr J, Rose C, Briery C . Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol. 2006; 195(4):914-34. DOI: 10.1016/j.ajog.2005.08.044. View

18.

Dusse L, Alpoim P, Silva J, Rios D, Brandao A, Cabral A . Revisiting HELLP syndrome. Clin Chim Acta. 2015; 451(Pt B):117-20. DOI: 10.1016/j.cca.2015.10.024. View

19.

Evensen A, Anderson J, Fontaine P . Postpartum Hemorrhage: Prevention and Treatment. Am Fam Physician. 2017; 95(7):442-449. View

20.

Sibai B, Ramadan M, Usta I, Salama M, Mercer B, FRIEDMAN S . Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol. 1993; 169(4):1000-6. DOI: 10.1016/0002-9378(93)90043-i. View